Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02506114
Title Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

prostate adenocarcinoma

Therapies

PROSTVAC-F-TRICOM + PROSTVAC-V-TRICOM

Ipilimumab

Ipilimumab + PROSTVAC-F-TRICOM + PROSTVAC-V-TRICOM

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.